![Imogene Dunn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Imogene Dunn
Direktor/Vorstandsmitglied bei
Data Quality Research Institute
Profil
Imogene Dunn is currently the Director at Data Quality Research Institute and the Senior Vice President-Biometrics & Regulatory at vTv Therapeutics LLC.
Previously, she worked as the VP-Statistics, Data Management & Informatics at Regeneron Pharmaceuticals, Inc. from 2003 to 2008.
She also held positions as Vice President-Data Sciences Strategic Services at PAREXEL International Corp., Vice President at Cato Research LLC, Vice President-Statistics & Data Management at Yamanouchi Pharma America, Inc., and Senior Vice President-Biometrics & Regulatory at vTv Therapeutics, Inc. Dr. Dunn received her undergraduate and graduate degrees from The University of North Carolina at Greensboro and her doctorate from The University of North Carolina at Charlotte.
Aktive Positionen von Imogene Dunn
| Unternehmen | Position | Beginn |
|---|---|---|
Data Quality Research Institute | Direktor/Vorstandsmitglied | - |
vTv Therapeutics LLC
 vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures human therapeutics to fill unmet medical needs | General Counsel | - |
Ehemalige bekannte Positionen von Imogene Dunn
| Unternehmen | Position | Ende |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2008 |
Yamanouchi Pharma America, Inc. | Corporate Officer/Principal | - |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Corporate Officer/Principal | - |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
| VTV THERAPEUTICS INC. | General Counsel | - |
Ausbildung von Imogene Dunn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Cato Research LLC
Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Commercial Services |
Yamanouchi Pharma America, Inc. | |
The University of North Carolina at Greensboro
 The University of North Carolina at Greensboro Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
 vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
Data Quality Research Institute | |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures human therapeutics to fill unmet medical needs | Health Technology |
